Related Experiment Video
Updated: Nov 11, 2025
Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
Published on: October 14, 2025
Clinical Aspects and Treatments for Pediatric Inflammatory Bowel Diseases
1Department of Pediatrics, Seoul National University Children's Hospital, Seoul National University College of Medicine, Seoul, Korea.
Insights
Pediatric inflammatory bowel disease (IBD) is rising globally. Early biologic therapy may benefit high-risk children, but risk stratification tools are needed for optimal treatment.
Area of Science:
- Pediatric gastroenterology
- Immunology
- Genetics
Background:
- Global incidence of pediatric inflammatory bowel disease (IBD) is increasing.
- Pediatric IBD presents differently from adult IBD, with distinct genetic factors and more aggressive inflammation.
- Biologic therapies, including anti-tumor necrosis factor α agents, show promise in managing pediatric IBD.
Purpose of the Study:
- To review the current understanding of pediatric IBD.
- To explore the potential benefits of early biologic intervention in high-risk pediatric IBD patients.
- To highlight the need for risk stratification tools in guiding biologic therapy for pediatric IBD.
Main Methods:
- Literature review of recent studies on pediatric IBD.
- Analysis of clinical manifestations and genetic predispositions in pediatric IBD.
- Evaluation of the role of biologics and risk factors in treatment decisions.
Main Results:
- Pediatric IBD shows increased incidence and distinct characteristics compared to adult IBD.
- High-risk pediatric IBD patients may benefit from earlier initiation of biologic therapies.
- Current treatment strategies aim to balance symptom relief, growth optimization, and quality of life while minimizing toxicity.
Conclusions:
- Effective management of pediatric IBD requires tailored approaches, considering disease severity and genetic factors.
- Further research is essential to develop reliable tools for stratifying risk and guiding the use of biologics in pediatric IBD.
- Optimizing treatment outcomes necessitates a comprehensive strategy focusing on growth, quality of life, and minimizing adverse drug effects.
Abstract:
The incidence of pediatric inflammatory bowel disease (IBD) is increasing worldwide, especially in the developing countries. It differs from adult disease in clinical manifestations, especially with regard to genetic predisposition in monogenic IBD. Pediatric disease also have a tendency to show more aggressive inflammation and greater extent of lesion. Newer drugs such as anti-tumor necrosis factor α have been known to make a difference in treating pediatric IBD. Recent studies suggested that the patients with high risk factors might have some benefits from earlier use of biologics. To achieve treatment goals such as relieving symptoms, optimizing growth, and improving quality of life while minimizing drug toxicity, more research is needed to develop tools for risk stratification in the use of biologics for pediatric IBD.
Related Concept Videos
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
01:17Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:21Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD: